GRIFOLS SA (1GRF.MI) Stock Price, Forecast & Analysis
BIT:1GRF • ES0171996087
1GRF.MI Key Statistics, Chart & Performance
The current stock price of 1GRF.MI is 10.835 EUR.
1GRF.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1GRF.MI.
1GRF.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1GRF.MI. 1GRF.MI has only an average score on both its financial health and profitability.
1GRF.MI Financial Highlights
Over the last trailing twelve months 1GRF.MI reported a non-GAAP Earnings per Share(EPS) of 0.55. The EPS increased by 160.05% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.96% | ||
| ROA | 1.88% | ||
| ROE | 7.2% | ||
| Debt/Equity | 1.76 |
1GRF.MI Forecast & Estimates
20 analysts have analysed 1GRF.MI and the average price target is 14.49 EUR. This implies a price increase of 33.7% is expected in the next year compared to the current price of 10.835.
For the next year, analysts expect an EPS growth of 40.91% and a revenue growth 5.37% for 1GRF.MI
1GRF.MI Ownership
1GRF.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1AE | ARGENX SE | 25.21 | 40.274B | ||
| ARGX | ARGENX SE | 25.14 | 40.187B | ||
| 22UA | BIONTECH SE-ADR | N/A | 22.567B | ||
| ABVX | ABIVAX SA | N/A | 7.876B | ||
| 2X1 | ABIVAX SA | N/A | 7.852B | ||
| GLPG | GALAPAGOS NV | N/A | 1.906B | ||
| GXE | GALAPAGOS NV | N/A | 1.904B | ||
| NANO | NANOBIOTIX | N/A | 1.311B | ||
| 6IV | INVENTIVA SA | N/A | 1.174B | ||
| IVA | INVENTIVA SA | N/A | 1.096B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1GRF.MI
Company Profile
Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. The company is headquartered in Sant Cugat Del Valles, Barcelona and currently employs 23,833 full-time employees. The company went IPO on 2006-05-17. The firm organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Company Info
GRIFOLS SA
Parque Empresarial Can Sant Joan, Avinguda de la Generalitat, 152-158
Sant Cugat del Valles BARCELONA ES
Employees: 23833
Phone: 34935710000
GRIFOLS SA / 1GRF.MI FAQ
Can you describe the business of GRIFOLS SA?
Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. The company is headquartered in Sant Cugat Del Valles, Barcelona and currently employs 23,833 full-time employees. The company went IPO on 2006-05-17. The firm organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
What is the current price of 1GRF stock?
The current stock price of 1GRF.MI is 10.835 EUR. The price decreased by -11.44% in the last trading session.
Does GRIFOLS SA pay dividends?
1GRF.MI does not pay a dividend.
What is the ChartMill rating of GRIFOLS SA stock?
1GRF.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Is GRIFOLS SA (1GRF.MI) expected to grow?
The Revenue of GRIFOLS SA (1GRF.MI) is expected to grow by 5.37% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the employee count for 1GRF stock?
GRIFOLS SA (1GRF.MI) currently has 23833 employees.